Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-10-14
1990-03-06
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 8, 544 9, 544 68, 544182, 544238, 544239, 544405, 544408, 546300, 546301, 546277, 548136, 548144, C07D40110, C07D41710, C07D41310, A61K 3150
Patent
active
049066285
ABSTRACT:
Phosphodiesterase (type III) inhibitors having the formula: ##STR1## which are useful in stimulating cardiac activity and in treating congestive heart failure and bronchoconstriction, pharmaceutical compositions including these inhibitors, and methods of using these compounds to produce phosphodiesterase (type III) inhibition in mammals.
REFERENCES:
Davis et al., Chem. Abs. 108, 48712j (1987).
Berch Mark L.
Lourie Alan D.
McCarthy Mary E.
Smith Kline & French Laboratories Limited
Suter Stuart R.
LandOfFree
N-phenylpyridone type III phosphodiesterases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-phenylpyridone type III phosphodiesterases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-phenylpyridone type III phosphodiesterases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-47606